iCrowd Newswire
27 Oct 2021, 03:49 GMT+10
The global Biosimilars market was valued at USD 8.69 Billion in 2020 and is expected to reach USD 72.74 Billion by year 2028, at a CAGR of 30.8%. Biosimilar are alternatives to existing patented, and approved biologicss and possess similar medicinal properties as compared to the original biologics. The biosimilars vary a little from original biologics in terms of structure but must have similar safety and efficacy as compared to the originator biologics. Biosimilars development does not require Phase II clinical trial for approval and the focus is put on determination of 'biosimilarity' to the reference originator biologics. Thus it has much reduced clinical development timelines and reduced product costs as compared to use of original biologics.
The global market is driven by various of factors such as global prevalence of target disease prevalence across the globe, launch of biosimilars by various market players, favorable investments scenario, and upcoming patent expiry.
The Biosimilars market is characterized by presence of significant number of pharmaceutical giants as well as emerging players operating across the globe. Additionally, availability of research fundings, demand for cheaper biologics alternative and favorable regulatory scenario in Europe and Asia pacific is propelling the market in these regions. However, some regions such as U.S are facing slow adoption of biosimilars with first biosimilar approved in 2015 for Sandoz's Zarxio (filgrastim), and 3, 5, and 7, biosimilars approved by FDA in 2016, 2017, and 2018, respectively..
Top Companies Profiled in the Report Include:
Amgen
Biocon
Celltrion
Dr. Reddy's Laboratories
Mylan
Pfizer
Samsung Biologics
Sandoz
Stada Arzneimittel
Teva Pahrmaceutical
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1177
Further key findings from the report suggest:
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1177
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Biosimilars market in these key regions.
Country-wise regional analysis covers:
To know more about the report @ https://www.reportsanddata.com/press-release/biosimilars-market
Additionally, the report consists a detailed analysis of the segmentation of the Biosimilars market based on product types and end-use/application offered in the Biosimilars market.
Type (Revenue, USD Million; 2018–2028)
Recombinant Non-glycosylated Proteins
Insulin
Recombinant Human Growth Hormone
Granulocyte Colony-stimulating Factor
Filgrastim
Pegfilgrastim
Interferons
Interferon-Beta
Interferon-Alpha
Recombinant Glycosylated Proteins
Erythropoietin
Monoclonal Antibodies
Adalimumab
Bevacizumab
Infliximab
Rituximab
Trastuzumab
Other Monoclonal Antibodies
Follitropin
Etanercept
Recombinant Peptides
Glucagon
Calcitonin
Disease Type (Revenue, USD Million; 2018–2028)
Oncology
Blood Disorders
Chronic Diseases
Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1177
Read More Reports –
Pharmacogenomics (PGx) Market - https://www.7newswire.com/press-release/pharmacogenomics-pgx-market-segmentation-industry-analysis-by-production-consumption-revenue-and-growth-rate-by-2027-reports-and-data/
Mammography Equipment Market - https://www.7newswire.com/press-release/mammography-equipment-market-size-top-countries-data-industry-share-company-overview-industrial-statistics-regional-economy-development-and-forecast-to-2028/
Non-Small Cell Lung Cancer Market - https://www.7newswire.com/press-release/non-small-cell-lung-cancer-market-investment-opportunities-industry-share-trend-analysis-report-to-2028-reports-and-data/
Immunoassay Analyzers Market - https://www.7newswire.com/press-release/immunoassay-analyzers-market-revenue-statistics-industry-growth-and-demand-analysis-research-report-by-2027-reports-and-data/
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Tags: Biosimilars market 2021, Biosimilars Market Covid 19, Biosimilars Market Trend, Biosimilars Market Growth, Biosimilars Market Size, Biosimilars Market Demand, Biosimilars Market Share
See Campaign: https://www.reportsanddata.com/report-detail/global-biosimilars-marketContact Information:
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Tags:PR-Wirein, Menafn, Reportedtimes, iCN Internal Distribution, Research Newswire, EnglishGet a daily dose of Philadelphia Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Philadelphia Herald.
More InformationWASHINGTON, D.C.: The Trump administration is weighing a major expansion of its travel restrictions, with a new internal memo revealing...
ARLINGTON COUNTY, Virginia: As global air travel continues its recovery from the pandemic, Boeing has released a tempered 20-year outlook...
NEW YORK, New York - U.,S. stocks closed lower Tuesday as President Donald Trump hinted the United States may join Israel in its attacks...
MENLO PARK, California: Meta Platforms has made a bold move to accelerate its artificial intelligence ambitions—by investing US$14.3...
WASHINGTON, D.C.: This week, President Donald Trump signed an executive order that facilitates Nippon Steel's potential investment...
MOUNTAIN VIEW, California: On June 12, Google announced that it had fixed a temporary global service disruption that impacted several...
NEW DELHI, India: The flight data recorder from the crashed Air India plane was found on June 13. This vital discovery may help investigators...
BEIJING, China: A typhoon altered its course and struck Hainan Island, southern China, late on the night of June 13. Typhoon Wutip...
BANFF, Alberta: The recent G7 summit has convened for the second and final day in the picturesque Canadian Rockies amidst escalating...
JOHANNESBURG, South Africa: A key global plan to end AIDS as a public health threat by 2030 is now in deeper jeopardy after the United...
CALGARY, Alberta, Canada - U.S. President Donald Trump has announced he is leaving the G7 summit after just one day, and after refusing...
HOUSTON, Texas: Crude oil surged to multi-month highs this week, driven by escalating tensions in the Middle East after Israel launched...